Description
The authors propose TNFα as the mediator of NP-1’s anti-obesity effects through hypothalamic anorectic actions, but provide no mechanistic evidence for this pathway. Understanding this TNFα-hypothalamic mechanism is crucial since it represents a novel obesity treatment target that bypasses adiponectin.
Gap type: unexplained_observation Source paper: The adiponectin promoter activator NP-1 induces high levels of circulating TNFα and weight loss in obese (fa/fa) Zucker rats. (2018, Scientific reports, PMID:29959379)